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ABSTRACT
Alternative splicing of pre-mRNAs is a major contributor to both proteomic diversity and control of gene expression levels.
Splicing is tightly regulated in different tissues and developmental stages, and its disruption can lead to a wide range of human
diseases. An important long-term goal in the splicing field is to determine a set of rules or ‘‘code’’ for splicing that will enable
prediction of the splicing pattern of any primary transcript from its sequence. Outside of the core splice site motifs, the bulk of
the information required for splicing is thought to be contained in exonic and intronic cis-regulatory elements that function by
recruitment of sequence-specific RNA-binding protein factors that either activate or repress the use of adjacent splice sites.
Here, we summarize the current state of knowledge of splicing cis-regulatory elements and their context-dependent effects on
splicing, emphasizing recent global/genome-wide studies and open questions.
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PRE-MRNA SPLICING
Because human genes typically contain multiple introns,
the process of pre-mRNA splicing is an essential step in
the expression of most genes. A majority of human genes
undergo alternative splicing (AS), generating multiple splic-
ing isoforms containing different combinations of exons
(Johnson et al. 2003). The effects of AS on protein products
can be dramatic, e.g., producing soluble versus membrane-
bound forms of the Fas receptor that have opposing effects
on apoptosis (Cascino et al. 1995), or producing isoforms
of the Drosophila fruitless protein that act to specify sexual
orientation (Demir and Dickson 2005). The major forms
of AS are summarized in Figure 1A. Splicing regulation has
been comprehensively described in several recent reviews
(Black 2003; Konarska and Query 2005; Matlin et al. 2005;
Blencowe 2006; House and Lynch 2008). Here, we briefly
summarize some aspects of splicing specificity and regula-
tion before turning to our main topic of splicing regulatory
elements and the rules governing their activity.
The sequential phosphodiester transfer reactions in-
volved in splicing are catalyzed by large ribonucleoprotein
complexes known as spliceosomes. Containing more than
100 core proteins and five small nuclear RNAs (snRNAs
U1, U2, U4, U5, and U6), spliceosomes may be the most
complex machines in the cell (Zhou et al. 2002; Jurica and
Moore 2003; Nilsen 2003). In addition to these core factors,
additional regulatory proteins participate in the splicing of
particular pre-mRNAs. Splicing of most introns is thought
to occur cotranscriptionally with fairly extensive interac-
tions between splicing factors and the core transcription
machinery (Das et al. 2006; Hicks et al. 2006). Splicing
mechanisms have also been well reviewed recently (Hertel
and Graveley 2005; Konarska and Query 2005).
CORE SPLICING SIGNALS
Three sites, the 59 splice site (59ss), the 39 splice site (39ss),
and the branch point sequence (BPS), participate in the
splicing reaction and are present in every intron, and thus
are known as the core splicing signals. These signals are
recognized multiple times during spliceosome assembly,
with the 59ss interacting initially with U1 and later with U6
snRNP, and the BPS interacting with SF1/mBBP and later
with U2 snRNP (Fig. 1B; Will and Lührmann 2007).
Because the 59ss and 39ss can be mapped precisely by
aligning cDNA or expressed sequence tag (EST) sequences
to the genome, large datasets of accurately annotated exon/
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intron structures can be obtained, permitting development
of statistical models of 59ss and 39ss motifs that capture
second-order statistical interactions between positions to
more accurately predict splice site locations (Yeo and Burge
2004). However, only a few dozen mammalian BPSs have
been mapped. The limited size of the available BPS data set
and the low information content of this motif make it
difficult to derive a reliable sequence model to predict BPSs
in introns. A recent study used comparative genomics to
improve BPS prediction (Kol et al. 2005), and more human
BPS sequences were identified recently by sequencing lariat
RT-PCR products (GAO et al. 2008).
EXON DEFINITION AS A KEY STEP
IN MAMMALIAN SPLICING REGULATION
A typical human gene contains relatively short exons
(typically, 50–250 base pairs [bp] in length) separated by
much larger introns (typically, hundreds to thousands of
base pairs or more) that on average
account for >90% of the primary tran-
script. This transcript geometry, and
the predominant exon-skipping pheno-
type of splice site mutations, are con-
sistent with the idea that in mammals
splice sites are predominantly recog-
nized in pairs across the exon through
‘‘exon definition’’ (Robberson et al. 1990;
Nakai and Sakamoto 1994; Sterner
et al. 1996). Exon definition involves
initial interaction across the exon
between factors recognizing the 59ss
and the upstream 39ss, whereas in the
alternative model, intron definition, in-
teractions occur first across the intron
between factors recognizing the 59ss
and the downstream 39ss (for review,
see Berget 1995). Recent analyses of the
coevolution of the 59ss and 39ss have
detected predominant cross-exon inter-
actions in human and mouse, but
cross-intron interactions in inverte-
brates, plants, and fungi, with puffer-
fishes representing an intermediate
state, supporting the primacy of exon
definition in mammals and intron def-
inition in most other metazoans (Xiao
et al. 2007). Because exon definition
occurs early during splicing and may
lead to commitment of the exon to
splicing, this step is critical for splicing
regulation and specificity. For example,
polypyrimidine tract binding protein
(PTB/hnRNP I) can inhibit exon defi-
nition complex formation by binding to
an ESS sequence causing skipping of Fas exon 6 (Izquierdo
et al. 2005); this same factor can also inhibit the spliceo-
some assembly across introns (intron definition) in repres-
sing splicing of the c-src N1 exon (Sharma et al. 2005).
Following initial splice site recognition in exon definition, a
series of sequential structural rearrangements is required to
activate the spliceosome, and commitment to alternative splice
site pairing may occur after initial splice site recognition
and E complex formation (Lim and Hertel 2004).
SPLICING REGULATORY ELEMENTS
AND ASSOCIATED FACTORS
Monte Carlo simulations inserting artificial motifs with
varying information content into transcripts in place of
natural splice sites have been used to estimate that the core
human splice site motifs contain only about half of the
information required to accurately define exon/intron
boundaries, even considering only short introns (Lim and
FIGURE 1. (A) Major forms of alternative splicing. In many cases, these common forms can
be combined to generate more complicated alternative splicing events. (B) A schematic of
regulated splicing. (Open boxes) Exons, (jagged lines) introns, (brackets) splice sites (ss). The
consensus motifs of ss are shown in pictogram, and the branch point adenosine is indicated.
(Dashed lines) Two alternative splicing pathways, with the middle exon either included or
excluded. Splicing is regulated by cis-elements (ESE, ESS, ISS, and ISE) and trans-acting
splicing factors (SR proteins, hnRNP, and unknown factors).
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Burge 2001). Large human introns typically contain nu-
merous ‘‘decoy’’ splice sites: sequences with similar score/
degree of consensus matching as authentic splice sites. Not
infrequently, decoy splice sites occur in pairs as ‘‘pseudo-
exons,’’ which resemble authentic exons in terms of length
and splice site strength, but are very rarely if ever spliced
(Sun and Chasin 2000). Despite the large potential for
errors, the splicing process appears to occur with very high
fidelity, implying the widespread involvement of transcript
features besides the core splice signals in splice site selec-
tion. This additional information is thought to derive in
large part from the presence of numerous cis-regulatory
elements that serve as either splicing enhancers or silencers.
These elements are conventionally classified as exonic splic-
ing enhancers (ESEs) or silencers (ESSs) if from an exonic
location they function to promote or inhibit inclusion of
the exon they reside in, and as intronic splicing enhancers
(ISEs) or silencers (ISSs) if they enhance or inhibit usage of
adjacent splice sites or exons from an intronic location. In
general, these splicing regulatory elements (SREs) function
by recruiting trans-acting splicing factors that activate or
suppress splice site recognition or spliceosome assembly by
various mechanisms (Matlin et al. 2005; Chasin 2007).
SREs have most often been identified by directed
mutagenesis of alternatively spliced genes and by analy-
sis of naturally occurring mutations that perturb splicing
of disease genes. ESEs are very abundant in constitutive
exons, but there is ample evidence that silencers play at
least as important a role in splicing regulation as enhancers
(Fairbrother et al. 2002; Wang et al. 2004; Zhang and
Chasin 2004). Based on the selective constraints on con-
stitutive exons for efficient and accurate splicing and on AS
exons for regulated splicing, enhancing elements are ex-
pected to play predominant roles in constitutive splicing, with
silencers being relatively more prominent in control of AS.
EXONIC SPLICING ENHANCERS AND SILENCERS
It is now well established that ESEs include a diverse range
of sequences, and many if not all exons contain internal
ESE sequences (Schaal and Maniatis 1999; Fairbrother et al.
2002; Cartegni et al. 2003). Most ESEs function by recruit-
ing members of the SR protein family (for review, see
Graveley 2000). These factors usually regulate splicing by
binding ESEs through their N-terminal RRM domains
and mediating protein–protein interactions that facilitate
spliceosome assembly through C-terminal RS domains
(Graveley and Maniatis 1998). However, at least for in
vitro splicing, the RS domains may not always be required
for ESE-dependent splicing activation (Shaw et al. 2007),
and RS domains can interact with RNA at the BPS and 59ss
during splicing complex assembly, at least in some cases
(Shen et al. 2004; Shen and Green 2006).
ESSs are often bound by splicing repressors of the
hnRNP class, a diverse group of proteins containing one
or more RNA-binding domains and sometimes splicing
inhibitory domains such as glycine-rich motifs (Pozzoli and
Sironi 2005). hnRNPs function by a wide variety of mech-
anisms. For example, PTB (hnRNP I) can block essential
interactions between U1 and U2 snRNPs (Izquierdo et al.
2005; Sharma et al. 2005), whereas hnRNP A1 can inhibit
splicing by binding on either side and ‘‘looping out’’ exons
or by directly displacing snRNP binding (Zhu et al. 2001;
Nasim et al. 2002). Other splicing inhibitory mechanisms
may also be used by these or other repressors.
Beyond molecular genetics, global approaches, including
both computational and experimental methods, have been
developed to identify ESEs and ESSs on a large scale (for
review, see Chasin 2007). ESEs have been identified ex-
perimentally by in vitro and in vivo SELEX approaches
(Tian and Kole 1995; Coulter et al. 1997; Liu et al. 1998,
2000). ESEs have also been computationally identified
based on their enrichment in authentic exons versus
introns and in exons with weak splice sites (Fairbrother
et al. 2002), and by their enrichment in authentic exons
versus pseudoexons and 59 UTRs of intronless genes
(Zhang and Chasin 2004). These studies have generated
comprehensive lists of ESE oligonucleotides that help
to predict the splicing phenotypes of exonic mutations
(Cartegni et al. 2002; Fairbrother et al. 2002; Pfarr et al.
2005). ESSs have also been predicted based on the assump-
tion that ESSs are depleted from authentic exons (Zhang
and Chasin 2004). We developed a cell-based fluorescence-
activated screen (FAS) and used it to identify 133 ESS
decanucleotides active in human cells from a library of
random sequences (Wang et al. 2004). Further analyses of
these FAS–ESS sequences suggested that ESSs play an
important role in distinguishing authentic exons from
pseudoexons and in regulating alternative splice site usage
and intron retention (Wang et al. 2004, 2006).
Additional exonic SREs have been predicted based on
sequence conservation (Goren et al. 2006), but the activities
of these elements as either splicing enhancers or silencers or
neutral sequences were observed to depend heavily on their
exonic context. It is not clear whether the context depen-
dence observed was due to the flexible activity of the
sequences tested, or resulted from alterations to endoge-
nous SREs in the reporters used. For example, all of the
sequences inserted into the SXN minigene promoted exon
skipping, which could be explained by disruption of an
unknown ESE in the site where the foreign sequences were
inserted (Goren et al. 2006). Other studies of ESSs have
found much greater consistency of function in different
exonic contexts (Wang et al. 2004, 2006).
INTRONIC SPLICING ENHANCERS AND SILENCERS
A number of intronic SREs are also known (for reviews, see
Ladd and Cooper 2002; Zheng 2004), but fewer large-scale
screens have been conducted for intronic elements, and
Wang and Burge
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many more intronic elements likely remain to be identified.
One well characterized ISE is the G triplet (GGG) or G run
(Gn; n $ 3), which often occur in clusters and can enhance
recognition of adjacent 59ss or 39ss (McCullough and
Berget 1997, 2000). This ISE is common in GC-rich introns
and is conserved between human and mouse (Yeo et al.
2004). Intronic CA repeats in several cases can enhance
splicing of upstream exons, probably through binding of
hnRNP L (Hui et al. 2005; Hung et al. 2007). UGCAUG
hexanucleotides or slight variations often occur down-
stream of neuron-specific exons and function as ISEs by
binding to the brain- and muscle-specific splicing factors
Fox-1/Fox-2 (Brudno et al. 2001; Jin et al. 2003; Minovitsky
et al. 2005; Nakahata and Kawamoto 2005; Underwood et al.
2005). Pairs of YCAY motifs (Y = C or U) are recognized
by the neuron-specific Nova family of splicing factors to
regulate a large number of splicing events in the brain
(Jensen et al. 2000; Ule et al. 2003). Interestingly, depend-
ing on their relative location in pre-mRNA, YCAY pairs can
also function as either ESSs or ISSs (Hui et al. 2005; Ule
et al. 2006). Such context dependence will be discussed in
more detail below.
Characterized ISSs include binding sites for the splicing
repressors PTB and hnRNP A1 (for reviews, see Zheng 2004;
Matlin et al. 2005), CA-rich sequences bound by hnRNP L
(Hui et al. 2005), specific octamers flanking exon IIIb of
the FGFR2 gene (Wagner et al. 2005), and two elements in
intron 7 of human SMN2, a therapeutic target for spinal
muscular atropy (Singh et al. 2006; Kashima et al. 2007).
Intronic elements (ISS and ISE) are likely of primary
importance in regulating AS events, as the intronic regions
surrounding alternative exons are far more conserved in
mammals than those surrounding constitutive exons, out
to a distance of 150 bp or more (Sorek and Ast 2003). Such
increased conservation has been used to predict unanno-
tated alternative exons (Sorek et al. 2004; Yeo et al. 2005),
and to predict intronic SREs (Voelker and Berglund 2007;
Yeo et al. 2007). In the predictions of intronic SREs, both
groups identified the Fox-1/2 binding motif UGCAUG as
the most conserved sequence near AS exons, and the
elements identified by Yeo and colleagues included most
known binding motifs associated with tissue-specific splic-
ing factors. Remarkably, not only the Fox-1/Fox-2 splicing
factor, but also its highly specific binding motif UGCAUG,
are conserved from nematodes to mammals (Kabat et al.
2006), indicating an ancient role in splicing regulation. The
analyses by Voelker and colleagues also suggested that the
AU-rich motifs are strongly associated with constitutive
splicing and may function as ISEs (Voelker and Berglund
2007); rigorous controls for GC content effects and experi-
mental tests will be needed to firmly establish this result.
Splicing enhancers and silencers often function addi-
tively, with additional copies increasing their effect on
splicing regulation (e.g., Huh and Hynes 1994; McCullough
and Berget 1997; Chou et al. 2000; Wang et al. 2004; Zhang
and Chasin 2004), either because they increase the affinity
of the associated factor (Dominguez and Allain 2006) or
because they increase the copy numbers of the factor that
are recruited, sometimes in synergistic fashion. Different
SREs may also function cooperatively to regulate alterna-
tive splicing. For example, exonic UAGG motifs and
intronic GGGG motifs overlapping the 59ss can function
cooperatively to silence the brain-specific CI cassette exon
(exon 19) of the glutamate NMDA R1 receptor gene (Han
et al. 2005); the purine-rich ESE in exon N1 of the c-src
gene can cooperate with the downstream G-run ISE to in-
crease exon N1 inclusion (Modafferi and Black 1999)
ELEMENTS THAT REGULATE INTRON RETENTION
Among the major types of alternative splicing, intron
retention is unique in that it does not involve a choice
between competing pairs of splice sites. Instead, it involves
the choice between using a pair of splice sites to excise an
intron and bypassing splicing to export intron-containing
mRNA to the cytoplasm. Therefore, intron retention is
probably regulated both by factors generally involved in
splicing—some of which may also play a role in mRNA
export—and by dedicated mRNA export factors (for review,
see Reed and Cheng 2005).
Many SREs that affect other types of AS can regulate
intron retention when properly situated (Sakabe and de
Souza 2007). For example, G-run ISEs can promote
splicing of a retained intron in human thrombopoietin
(Marcucci et al. 2007), and a subset of FAS–ESS elements
can activate splicing of a retained intron (Wang et al. 2006).
In addition, the CA-rich motifs that bind to hnRNP L can
enhance the splicing of multiple retained introns as
revealed by splicing microarray analyses following RNAi
against hnRNP L (Hung et al. 2007). Another intensely
studied case is the Drosophila P-element third intron
(INV3), which is retained in somatic cells but is fully
spliced in germ cells (Rio 1991). One element that pro-
motes intron retention is a 59ss-like sequence in the up-
stream exon (Siebel et al. 1992); similar 59ss-like sequences
have ESS activity in the ATM gene (Pagani et al. 2002) and
were identified in the FAS–ESS screen (Wang et al. 2004).
Some protein factors that regulate INV3 retention are
homologous with vertebrate proteins that regulate splicing
by binding to splicing enhancers or silencers (Siebel et al.
1994, 1995; Min et al. 1997). Therefore, it is reasonable to
speculate that most general SREs can also regulate intron
retention since they usually have a direct effect on splice
site activity.
Perhaps the best-studied systems involving regulated
intron retention occur in retroviruses (e.g., HIV) that need
to balance between splicing of mRNA and transport of
unspliced genomic RNA to the cytoplasm for packaging
(Fischer et al. 1999). Retroviruses use many general SREs to
regulate splicing of their RNA (for review, see Stoltzfus and
Assembling a splicing code
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Madsen 2006) and also use RNA elements to regulate
nuclear export of unspliced RNA (for reviews, see Pollard
and Malim 1998; Cullen 2003). How HIV RNAs balance
between the two pathways is not completely clear, but some
common elements might serve as a functional bridge
between the two pathways by participating in the regula-
tion of both splicing and RNA export (e.g., an ESS
recognized by hnRNP A1 [Asai et al. 2003] and the Rev
response elements [Pongoski et al. 2002]).
CONTEXT DEPENDENCE OF SRES
It was realized early in the study of splicing that the ac-
tivities of SREs may depend on the relative locations of the
elements in pre-mRNAs. For example, G triplets com-
monly enhance splicing from intronic locations (McCullough
and Berget 1997), but they function as splicing silencers
when located in exons (Chen et al. 1999). A more subtle
effect is that the activity of SR proteins to promote splicing
depends on the distance between the ESE and the adjacent
splice site (Graveley et al. 1998). In some cases, the SREs
identified in one AS event fail to regulate splicing when
located in a heterologous exon/intron context. These
phenomena may be collectively described as the ‘‘context
dependence’’ of SREs and can be considered to fall into two
categories: (1) location-dependent activity, in which activ-
ity varies with relative positions in the pre-mRNA (Fig.
2A); and (2) gene-dependent activity, in which activity
observed in one gene is lost when the SRE is moved to
another (Fig. 2B).
Location-dependent activity reflects the flexibility of
splicing regulatory factors in their interactions with core
splicing machinery. Given the size and complexity of
spliceosomes and their multistep assembly, it is perhaps
not surprising that the activities of factors that interact
with core spliceosome components would vary depending
on their locations relative to these components. For
example, the G-run-binding factor hnRNP H can partici-
pate in a splicing enhancer complex when G runs are
located downstream of the 59ss (Chou et al. 1999;
Caputi and Zahler 2001; Hastings et al. 2001; Schaub et al.
2007) but can inhibit splicing when similar sequences are
located in an exon (Chen et al. 1999; Caputi and Zahler
2001).
Although the degree of context dependence of SREs may
initially appear chaotic or confusing, there are usually
patterns and rules that summarize this activity. For exam-
ple, the dual activity of G runs as ISEs and ESSs can be
conceptually interpreted as defining a region of pre-mRNA
as intron rather than exon. We have observed that most
ESSs inhibit the intron-proximal 59ss or 39ss when located
between competing alternative splice sites, and that some
ESSs, including G runs, can promote splicing of retained
introns when located inside the intron (Wang et al. 2006).
The underlying mechanism for these activities of G runs
could involve inhibition by hnRNP F/H of exon definition
complex formation ‘‘across’’ the site of binding. As noted
above, clusters of YCAY motifs that bind the Nova family
of neuron-specific splicing factors can function as ESSs,
ISEs, or ISSs, depending on their position relative to the
regulated exon. An ‘‘RNA map’’ describing these context-
dependent activities has been generated that predicts the
direction of Nova-dependent splicing regulation with very
high accuracy (Ule et al. 2006). This study, including also a
dissection of the mechanisms of splicing activation and
repression by Nova, represents an important demonstra-
tion that the set of splicing regulatory activities of a factor
can be rationalized.
Analogous to the common overlap between ESSs and
ISEs, some SR proteins can promote splicing when bound
to sites (ESEs) in exons, and also inhibit splicing when
bound to intronic (ISS) sites (Kanopka et al. 1996; Ibrahim
el et al. 2005; Buratti et al. 2007). Results of a FAS-based
screen for ISSs suggest that overlap between ISS and ESE
activity could be a general phenomenon (Z. Wang, J.
Zhang, X. Xiao, and C.B. Burge, unpubl.). A recent report
suggested the counterintuitive result that some elements
(designated ‘‘ESRs’’) can function as both ESSs and ESEs
depending on exonic context (Goren et al. 2006). However,
in our own analyses, large sets of ESEs and ESSs identified
using entirely different methods (statistically-based and
experimentally-based) were nonoverlapping, suggesting
that a single sequence is unlikely to commonly function
as both an ESS and an ESE (Fairbrother et al. 2002; Wang
et al. 2004).
FIGURE 2. Schematic of two types of context dependence for SREs.
(A) Location-dependent activity of SREs, in which activity varies with
pre-mRNA position. For example, G runs can function as both ESSs
and ISEs (upper panel), and some SR protein binding sites can
function as both ESEs and ISSs (lower panel). (Yellow) Alternative
exons; (blue) constitutive exons. (B) Gene-dependent activity of SREs,
in which activity observed in one gene is lost when the SRE is moved
to another. Different genes are shown in different colors.
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For intronic elements, the situation is much more
complex. For example, Nova binding sequences commonly
function as ISEs when located near the splice sites of the
intron downstream of the regulated exon and as ISSs when
located near the 59ss of the upstream intron (Ule et al.
2006). Similarly, the Fox-1/2 binding site (UGCAUG) can
function as an ISS when located upstream of an exon (Jin
et al. 2003) and as an ISE when located downstream of an
alternative exon (Huh and Hynes 1994; Lim and Sharp
1998; Jin et al. 2003). CA repeats bound by hnRNP L can
function either as ISEs or ISSs depending on their distance
to the upstream exon (Hui et al. 2005).
Gene-dependent activity of SREs may often result from
factors that determine whether a cis-element can be re-
cognized by the associated factor. Because most splicing
regulatory cis-elements are short RNA oligonucleotides,
they tend to be very abundant in pre-mRNA. Based on a
recent comparative analysis of exonic splicing elements, it
was estimated that about 1000 hexamers can function as
either ESSs or ESEs (Stadler et al. 2006). Therefore, every
pre-mRNA will contain many potential splicing regulatory
motifs, only a fraction of which may be recognized by
trans-factors. This is analogous to transcriptional regula-
tion in that a search near a promoter region will predict a
large number of transcription factor binding sites, only a
small fraction of which are functional. Determining which
cis-elements will be recognized remains an open problem.
One obvious factor is the local structure of the pre-mRNA,
which could affect cis-element accessibility. For example,
RNA structure in the fibronectin EDA exon appears to
affect recognition of an ESE by SR proteins, and this
structure accounts for much of the difference between the
splicing behavior of the orthologous exons in human and
mouse (Buratti et al. 2004). A recent analysis of experi-
mentally determined SREs suggested that these SRE motifs
are significantly enriched in single-stranded regions of pre-
mRNA (Hiller et al. 2007), suggesting that pre-mRNA
secondary structure may play a general role in determining
SRE function. Some factors, including Nova and muscle-
blind-like splicing factors, recognize their cognate motifs in
specific structural contexts (Jensen et al. 2000; Warf and
Berglund 2007).
In addition to affecting SRE accessibility, secondary
structures may also regulate splicing by directly affecting
splice site accessibility. For example, a stem–loop structure
at the 59ss of exon 10 of the human tau gene directly affects
the activity of the 59ss, with stabilization of this structure
decreasing exon 10 inclusion and destabilization of this
stem–loop increasing exon 10 inclusion (Donahue et al.
2006). Another remarkable example was found in exon 6 of
the Drosophila Dscam gene, where the intronic secondary
structure ensures that inclusion of 48 alternative exons
occurs in a mutually exclusive fashion (Graveley 2005).
However, it is unclear whether examples like this represent
unusual cases or are a general rule, and even for tau exon
10 the role of structure in splicing regulation is debated
(D’Souza and Schellenberg 2002). Spliceosomes contain
multiple RNA helicase components that can unwind RNA
structures and remodel RNA/protein complexes (for re-
view, see Bleichert and Baserga 2007). Although the
primary function of these spliceosome-associated helicases
appears to be rearrangement of snRNA/snRNA, snRNA/
pre-mRNA, and snRNA/protein interactions in the spli-
ceosome, at least one appears to function at an earlier stage,
influencing the alternative splicing of the CD44 pre-mRNA,
possibly by remodeling its structure and/or associated pro-
tein complexes (Honig et al. 2002; Lee 2002). By analogy
to translation, where ribosome-associated helicases alter
mRNA structure to facilitate translocation, it is tempting to
speculate that spliceosome-associated helicases may also
disrupt splicing-inhibitory structure in pre-mRNAs. As the
general roles of structure in splicing regulation are still not
clearly defined, large-scale measurements of RNA struc-
tures should be very valuable. Some recently developed
methods like selective 29-hydroxyl acylation and primer
extension (SHAPE) provide new possibilities for high-
throughput measurements of RNA structures (Merino et al.
2005), but high-throughput methods capable of assessing
structure in vivo still need to be developed.
The activities of SREs are of course dependent on the
presence and activity of the associated trans-factors, and this
dependence is probably responsible for most of the tissue-
or cell-type-specific splicing. SRE activity can also respond
to external signals that alter the expression or activity of
specific trans-factors (for review, see Shin and Manley
2004). The mechanisms by which inducible splicing
responds to different stimuli can be very diverse, including,
but not limited to, neuronal depolarization through CaM
kinase (Xie and Black 2001; Lee et al. 2007), heat shock
response through SR protein dephosphorylation (Shin and
Manley 2002; Shin et al. 2004), response to T cell activation
through an inducible ESS bound by hnRNP L (Rothrock
et al. 2003, 2005), and response to neuronal excitation through
a UAGG motif recognized by hnRNP A1 (Han et al. 2005).
GLOBAL ANALYSES OF SPLICING REGULATION
A number of new technologies have been developed
recently for genome-wide analysis of AS. Several micro-
array platforms have been designed to distinguish between
different splicing isoforms and to detect AS at a genomic
scale. ‘‘Exon junction arrays’’ represent one early design,
with high-density oligonucleotide probes targeted to the
junctions between consecutive exons (Johnson et al. 2003).
Other designs include the use of probe sets to target bodies
and junctions of constitutive and alternative exons (Clark
et al. 2002; Pan et al. 2004; Blanchette et al. 2005; Sugnet
et al. 2006), as well as the use of bead-based fiber-
optic microarray platforms with high detection sensitivity
(Yeakley et al. 2002). These designs have facilitated analyses
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of genome-wide alternative splicing in human, mouse, and
chimp (Srinivasan et al. 2005; Boutz et al. 2007; Calarco
et al. 2007; Ip et al. 2007; Ni et al. 2007), as well as detection
of the global impact of specific splicing factors or environ-
mental stimuli on splicing regulation (Park et al. 2004;
Hung et al. 2007; Makeyev et al. 2007; Pleiss et al. 2007a,b).
A very high-density ‘‘exon array’’ containing probes in es-
sentially all known and predicted human exons was re-
cently developed by Affymetrix (Gardina et al. 2006).
Generally speaking, these array platforms appear able to
identify a subset of AS events with high confidence, but have
an unknown and probably substantial rate of false negatives.
The systematic identification of RNA targets for different
trans-factors can also be achieved by some new approaches
such as a cross-linking/immunoprecipitation (CLIP) (Ule
et al. 2003), RNP immunoprecipitation (RIP) (Keene et al.
2006; Townley-Tilson et al. 2006), and genomic SELEX
(Lorenz et al. 2006). These analyses have the potential to
identify regulatory targets of a factor and can be applied
genome-wide when coupled with microarray or high-
throughput sequencing technologies. Analysis of the target
sequences will help to define the sequence determinants of
binding, and may also help to identify cooperative or
antagonistic relationships between different factors. Since
only a subset of binding events confers regulatory activity,
it is important to also have evidence of regulation. Such
evidence can be obtained from knockout/knockdown or
overexpression of the factor, which can be also applied on a
genome-wide scale when coupled with isoform-specific
microarrays (Blanchette et al. 2005), or with high-through-
put sequencing.
SPLICING SIMULATION:
PUTTING THE PIECES TOGETHER
An important long-term goal in the
splicing field is to determine a ‘‘splicing
code:’’ a set of rules that can predict the
splicing pattern of any primary tran-
script sequence (Fu 2004; Matlin et al.
2005). As large ‘‘parts lists’’ of splicing
regulatory cis-elements are identified,
and identities and functions of asso-
ciated trans-acting factors are de-
termined, a natural next step is to
assemble the available information into
a predictive framework to simulate the
recognition of exons and introns that
occurs during splicing. An initial ap-
proach to this very challenging prob-
lem was the development of the general
splicing simulation algorithm, Exon-
Scan (Fig. 3; Wang et al. 2004). The
goal of splicing simulation is to predict
the splicing patterns of transcripts
based only on the information that is accessible and known
(or strongly implicated) to be recognized by the nuclear
pre-mRNA splicing machinery. Thus, in addition to pre-
dictive accuracy, faithfulness to the in vivo mechanism is
important in splicing simulation, and an important appli-
cation of splicing simulation is to evaluate how different
sequence features contribute to the determination of
splicing specificity. This philosophy is different from that
of most gene prediction/gene finding algorithms, whose
goal is generally to make the most accurate prediction of
exon and gene locations using whatever information is
available. For example, most current gene finders use
reading frame consistency of exons and/or cross-species
conservation in their predictions, information that is inac-
cessible to the spliceosome.
The ExonScan algorithm, illustrated in Figure 3, involves
scanning the pre-mRNA for pairs of nearby potential 39ss
and 59ss, and scoring these sites and nearby exonic and
intronic SREs. Log-odds scoring is used, which rewards
elements based on their statistical enrichment in the
relevant location relative to their background frequency
in the genome and naturally assigns positive scores to
enhancers and negative scores to silencers. The results
generated with this algorithm provided important clues
to the in vivo function of ESSs (Wang et al. 2004). Such
simulation should be improved by use of more refined sets
of sequence elements and context-dependent scoring
schemes, and by consideration of the functional interac-
tions between different elements, as inferred from experi-
mental assays or from patterns of coevolution (Xiao et al.
2007).
FIGURE 3. Schematic diagram of a general splicing simulator, ExonScan. (Green boxes)
Splicing enhancers, (red boxes) silencers. For simplicity, only ESSs and ESEs are indicated. Step 1,
Identify the exon candidate as a pair of splice site (shown as brackets) that is 50–250 bp apart.
Step 2, Score the splice sites and splicing enhancers and silencers, and sum up for the score of
each exon candidate. Step 3, Determine the threshold and make the final prediction.
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The splicing regulatory network is part of a larger network
of gene regulation with which it is linked both physically
and functionally. Most introns are thought to be spliced
cotranscriptionally (de la Mata et al. 2003; Das et al. 2006;
Hicks et al. 2006), and SR proteins associate with the
C-terminal domain of RNA polymerase II (de la Mata and
Kornblihtt 2006; Das et al. 2007). As a downstream event of
transcription, AS can be regulated by factors that affect
transcription. For example, a mutated RNA polymerase II
with a slow elongation rate had been shown to affect the AS
of endogenous genes (de la Mata et al. 2003), and the
insertion of a transcription-pausing element, MAZ4, into a
minigene construct can influence splicing of an alternative
exon (Robson-Dixon and Garcia-Blanco 2004). Therefore,
it is tempting to speculate that some of the identified SREs
could act through effects on transcription, e.g., functioning
as a transcription pause site to promote the inclusion of a
weak upstream exon. In addition, the whole process of
mRNA biosynthesis and processing, including transcrip-
tion, 59 capping, splicing, polyadenylation, and transport
is extensively coupled, with a number of factors involved
in more than one step of this process (Hieronymus and
Silver 2004; Kornblihtt et al. 2004). The splicing regulation
network should therefore be viewed as a specialized sub-
network of a more general gene regulatory netwok.
PERSPECTIVE
Sorting out the complex network that controls constitutive
and alternative splicing represents a major challenge for
post-genomic biology. A promising route to such global
understanding is a ‘‘bottom-up’’ approach, involving sys-
tematic identification of the cis-regulatory components of
the network, determination of rules—context dependence
or otherwise—for their activity and functional interactions
with other elements, and integration of these rules into
simulation algorithms representing successive approxima-
tions to the splicing code. Beyond the challenges discussed
above, another important challenge will be to learn how to
generalize the cis-elements, factors, and rules identified in
one system (e.g., in one cell type or developmental stage) to
others. This will undoubtedly require new experimental
approaches that can be readily adapted to a variety of
systems.
Given the complexity of splicing regulation, the splicing
code will not have the simple tabular form of the genetic
code. Instead, it may look more like the U.S. tax code (i.e.,
IRS form 1040), with a variety of tables and subtables that
are applicable in different circumstances, and a certain
amount of arithmetic required to obtain the correct
answer.
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